Loading
FS
Forty Seven, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Lightspeed Venture Partners X, L.P., was filed 24 Jul 2019.
Forty Seven, Inc.: what insiders have been doing
Forty Seven, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Forty Seven, Inc. has had no insider filing for more than a year; the last one goes back to 7 April 2020.
Our records for Forty Seven, Inc. go back to 2018, with 20 purchases and 72 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
230
Thresholds
n/a
Buy Volume
€39M
20 ops. · all time
Sell Volume
€43M
72 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 7 April 2020
Declarations230 total
1,000 shares0Common StockSEC:0001209191-20-023723:0
1,060,400 sharesCommon StockSEC:0001209191-20-023723:1
100,000 sharesCommon StockSEC:0001209191-20-023723:2
100,000 sharesCommon StockSEC:0001209191-20-023723:3
47,327 sharesCommon StockSEC:0001209191-20-023715:3
5,924 sharesCommon StockSEC:0001209191-20-023715:4
562,500 sharesCommon StockSEC:0001209191-20-023727:0
233,564 sharesCommon StockSEC:0001209191-20-023727:1
215,375 sharesCommon StockSEC:0001209191-20-023727:2
6,596 sharesCommon StockSEC:0001209191-20-023727:3
9,124 shares0Common StockSEC:0001209191-20-023715:0
9,124 sharesCommon StockSEC:0001209191-20-023715:1
47,327 sharesCommon StockSEC:0001209191-20-023715:2
279,000 shares0Common StockSEC:0001209191-20-023724:0
16,772 shares0Common StockSEC:0001209191-20-023724:1
1,456,989 sharesCommon StockSEC:0001209191-20-023724:2
4,595 sharesCommon StockSEC:0001209191-20-023711:0
37,414 sharesCommon StockSEC:0001209191-20-023713:0
3,906 sharesCommon StockSEC:0001209191-20-023714:0
49,627 shares@ US$2.021.2% of flowCommon StockSEC:0001209191-20-023395:0
8,333 shares@ US$4.880.5% of flowCommon StockSEC:0001209191-20-023395:1
7,020 shares@ US$5.270.4% of flowCommon StockSEC:0001209191-20-023395:2
11,418 shares@ US$8.761.2% of flowCommon StockSEC:0001209191-20-023395:3
2,797 shares@ US$35.751.2% of flowCommon StockSEC:0001209191-20-023395:4
79,195 shares@ US$95.4287.7% of flowCommon StockSEC:0001209191-20-023395:5
25 of 230 declarations
About Forty Seven, Inc.
Forty Seven, Inc. is a biotechnology company focused on developing immuno-oncology therapies. It specializes in researching and commercializing treatments for cancer using innovative approaches.
